UK drug analysis prints and anaesthetic adverse drug reactions

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 3, 2007, Pages 316-328

  Holdcroft, Anita ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Adverse drug reactions; Allergy; Anaesthesia; Intensive care; Mortality

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANESTHETIC AGENT; ATRACURIUM; DESFLURANE; ENFLURANE; ETOMIDATE; FLUMAZENIL; GALLAMINE; HALOTHANE; ISOFLURANE; KETAMINE; KETOROLAC; LIDOCAINE; METHOHEXITAL; METHOXYFLURANE; MIDAZOLAM; NALOXONE; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PANCURONIUM; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; TRICHLOROETHYLENE; UNINDEXED DRUG; VECURONIUM;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ANGIONEUROTIC EDEMA; ANOREXIA NERVOSA; ANOXIA; ARTICLE; ASPHYXIA; ASPIRATION; ASTHMA; BLOOD CLOTTING DISORDER; BLOOD DISEASE; BRADYCARDIA; BRAIN EDEMA; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRONCHOSPASM; CARCINOMATOSIS; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLAUDICATION; COMA; CONGENITAL DISORDER; CONTROLLED STUDY; CONVULSION; DIABETIC KETOACIDOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INTOXICATION; DRUG MISUSE; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; ENDOCRINE DISEASE; EXTRASYSTOLE; EYE DISEASE; FETUS DISTRESS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GRAND MAL SEIZURE; HEARING DISORDER; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEPATOBILIARY DISEASE; HUMAN; HYPERSENSITIVITY REACTION; HYPERTHERMIA; HYPOTENSION; INFECTION; INJURY; KIDNEY DISEASE; LARYNX EDEMA; LIVER FAILURE; LIVER NECROSIS; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; METABOLIC ACIDOSIS; METABOLIC DISORDER; MORTALITY; MOTOR NEURON DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PERIPHERAL VASCULAR DISEASE; PHARMACOEPIDEMIOLOGY; PNEUMOTHORAX; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATION DEPRESSION; RESPIRATORY ARREST; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SEPTICEMIA; SIDE EFFECT; SINUS BRADYCARDIA; SKIN DISEASE; STILLBIRTH; SUDDEN DEATH; SUICIDE; THROMBOCYTOPENIA; UNITED KINGDOM;

ADMINISTRATION, INHALATION; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANALGESICS; ANESTHETICS; DATABASES; DRUG HYPERSENSITIVITY; GREAT BRITAIN; HUMANS; MORTALITY; NEUROMUSCULAR BLOCKING AGENTS; PHARMACOEPIDEMIOLOGY; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

EID: 33947264254     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1261     Document Type: Article

References (28)

1. Murdoch S, Cohen A. Intensive care sedation: a review of current British practice. Intensive Care Med 2000; 26: 922-928.
2. Riker RR, Fraser GL. Adverse events associated with prolonged use of sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 2005; 25: 8S-18S.
3. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 2001; 21: 1140-1144.
4. Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158: 1774-1782.
5. Korak-Leiter M, Likar R, Ober M, et al. Withdrawal following sufentanil/ propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids. Intensive Care Med 2005; 31: 380-387.
6. Fisher MM, Baldeo BA. The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. Ann Fr Anesth Réanim 1993; 12: 97-104.
7. Laxenaire MC et al. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicentre epidemiological inquiry. Ann Fr Annesth Ra̧nim 1993; 12: 91-96.
8. Laxenaire MC. Epidemiological survey of anaphylactoid reactions occurring during anaesthesia. Fourth French multicentre survey (July 1994 - December 1996) Ann Fr Anesth Reanim 1999; 18: 796-809.
9. Clarke RSJ, Watkins J. Drugs responsible for anaphylactoid reactions in anaesthesia in the United Kingdom. Ann Fr Anesth Réanim 1993; 12: 105-108.
10. Guldager H, Sondergaard I, Jensen FM, Cold G. Basophil histamine release in asthma patients after in vitro provocation with Althesin and Etomidate. Acta Anaesthesiol Scand 1985; 29: 3515.
11. Annane D. ICU physicians should abandon the use of etomidate! Intensive Care Med 2005; 31; 325-326.
12. Fellows IW, Bastow MD, Byrne AJ, Allison SP. Adrenocortical suppression in multiply injured patients: a complication of etomidate treatment. Br Med J (Clin Res Ed) 1983; 287: 1835-1837.
13. Ledingham IMcA, Finlay WEI, Watt I, McKee JI. Etomidate and adrenocortical function. Lancet 1983; 1: 1434.
14. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616.
15. Festa M, Bowra J, Schell D. Use of propofol infusion in Australian and New Zealand paediatric intensive care units. Anaesth Intensive Care 2002; 30: 786-793.
16. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med 2000; 28: 3071-3074.
17. Webb SA, Roberts B, Breheny FX, Golledge CL, Cameron PD, van Heerden PV. Contamination of propofol infusions in the intensive care unit: incidence and clinical significance. Anaesth Intensive Care 1998; 26: 162-164,
18. Han J, Davis SS, Washington C. Physical properties and stability of two emulsion formulations of propofol. Int J Pharm 2001; 14: 207-220.
19. Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol 2003; 17: 29-46.
20. Rosenberg PH, Kalso EA, Tupminen MK, Linden HB. Acute bupivacaine toxicity as a result of venous leakage under the tourniquet cuff during a Bier block. Anesthesiology 1983; 58: 95-98.
21. Santos AC, DeArmas PI. Systemic toxicity of levobupivacaine, bupivacaine and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes. Anesthesiology 2001; 95: 1256-1264.
22. Bellamy MC, Hopkins PM, Halsall PJ, Ellis FR. A study into the incidence of methaemogolobinaemia after 'three-in-one' block with prilocaine. Anaesthesia 1992; 47: 1084-1085.
23. Couper RT. Methaemoglobinaemia secondary to topical lignocaine/ prilocaine in a circumcised neonate. J Paediatr Child Health 2000; 36: 406-407.
24. Haverkos GP, DiSalvo RP, Imhoff TE. Fatal seizures after flumazenil administration in a patient with a mixed overdose. Ann Pharmacother 1994; 28: 1347-1349.
25. (No authors given) Treatment of benzodiazepine overdose with flumazenil. The flumazenil in benzodiazepine intoxication multicentre study group. Clin Ther 1992; 14: 78-95.
26. Hayashi Y, Sumikawa K, Yamatodami A, Kamibayashi T, Kuro M, Yoshiya I. Myocardial epinephrine sensitisation with subanaesthetic concentrations of halothane in dogs. Anesthesiology 1991; 74: 134-137.
27. Holdcroft A, Morgan M, Whitwam JG, Lumley J. Effect of dose and premedication on induction complications with etomidate. Br J Anaesth 1976; 48: 199-204.
28. Krieger W, Copperman J. Seizures with etomidate anaesthesia. Anesthesia and Analgesia 1985; 64: 1223.